Why Pfizer Is Betting Big On An Unproven Treatment For COVID-19 On the first Monday of May, Pfizer dosed the initial batch of healthy American volunteers in Baltimore with an experimental Covid-19 vaccine it developed with Germanyâs Bio-NTech.